Table 4.
Summary of Changes in HF Epidemiology between 1990–2009
2000–2009 (vs. 1990–1999) | |
---|---|
| |
Incidence | |
All HF | ← → |
HFREF | ↓ |
HFPEF | ↑ |
| |
CVD and non-CVD Mortality* | |
All HF | ← → |
HFREF | ← → |
HFPEF | ← → |
| |
Prevalent use of cardiovascular meds in HF | |
Aspirin | ↑ |
Beta blockers | ↑ |
Angiotensin-converting enzyme inhibitors | ← → |
Lipid-lowering medications | ↑ |
Diuretics | ↓ |
Digoxin | ↓ |
There was no change between decades in mortality for overall mortality, CVD mortality, or non-CVD mortality.